Role of c-Jun N-terminal kinase (JNK) in obesity and type 2 diabetes
JHM Yung, A Giacca - Cells, 2020 - mdpi.com
Obesity has been described as a global epidemic and is a low-grade chronic inflammatory
disease that arises as a consequence of energy imbalance. Obesity increases the risk of …
disease that arises as a consequence of energy imbalance. Obesity increases the risk of …
Oxidative stress in obesity-associated hepatocellular carcinoma: sources, signaling and therapeutic challenges
Obesity affects more than 650 million individuals worldwide and is a well-established risk
factor for the development of hepatocellular carcinoma (HCC). Oxidative stress can be …
factor for the development of hepatocellular carcinoma (HCC). Oxidative stress can be …
[HTML][HTML] Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma
S Talamantes, M Lisjak, EH Gilglioni… - JHEP Reports, 2023 - Elsevier
Obesity-related complications such as non-alcoholic fatty liver disease (NAFLD) and type 2
diabetes (T2D) are well-established risk factors for the development of hepatocellular …
diabetes (T2D) are well-established risk factors for the development of hepatocellular …
[HTML][HTML] Oxidative stress and redox signaling in the pathophysiology of liver diseases
The increased production of derivatives of molecular oxygen and nitrogen in the form of
reactive oxygen species (ROS) and reactive nitrogen species (RNS) lead to molecular …
reactive oxygen species (ROS) and reactive nitrogen species (RNS) lead to molecular …
PYCR1 interference inhibits cell growth and survival via c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathway in hepatocellular cancer
J Zhuang, Y Song, Y Ye, S He, X Ma, M Zhang… - Journal of translational …, 2019 - Springer
Background Liver cancer is the second leading causes of cancer-related death globally.
Pyrroline-5-carboxylate reductase 1 (PYCR1) plays a critical role in metabolic profiles of …
Pyrroline-5-carboxylate reductase 1 (PYCR1) plays a critical role in metabolic profiles of …
JNK signaling pathway in metabolic disorders: An emerging therapeutic target
Metabolic Syndrome is a multifactorial disease associated with increased risk of
cardiovascular disorders, type 2 diabetes mellitus, fatty liver disease, etc. Various stress …
cardiovascular disorders, type 2 diabetes mellitus, fatty liver disease, etc. Various stress …
Exercise inhibits JNK pathway activation and lipotoxicity via macrophage migration inhibitory factor in nonalcoholic fatty liver disease
N Cui, H Li, Y Dun, JW Ripley-Gonzalez… - Frontiers in …, 2022 - frontiersin.org
The macrophage migration inhibitory factor (MIF) expressed in hepatocytes can limit
steatosis during obesity. Lipotoxicity in nonalcoholic fatty liver disease is mediated in part by …
steatosis during obesity. Lipotoxicity in nonalcoholic fatty liver disease is mediated in part by …
Adiposity and serum selenium in US adults
Q Zhong, R Lin, Q Nong - Nutrients, 2018 - mdpi.com
Requirements for selenium and other antioxidant nutrients are increased in pro-oxidant and
pro-inflammatory conditions such as excess adiposity. Data concerning the association of …
pro-inflammatory conditions such as excess adiposity. Data concerning the association of …
JNK1 and ERK1/2 modulate lymphocyte homeostasis via BIM and DRP1 upon AICD induction
Abstract The Activation-Induced Cell Death (AICD) is a stimulation-dependent form of
apoptosis used by the organism to shutdown T-cell response once the source of …
apoptosis used by the organism to shutdown T-cell response once the source of …
Molecular genealogy of metabolic-associated hepatocellular carcinoma
T Kodama, T Takehara - Seminars in Liver Disease, 2024 - thieme-connect.com
This review examines the latest epidemiological and molecular pathogenic findings of
metabolic-associated hepatocellular carcinoma (HCC). Its increasing prevalence is a …
metabolic-associated hepatocellular carcinoma (HCC). Its increasing prevalence is a …